BofA raises Thermo Fisher target to USD 745 from USD 650 for Thermo Fisher Scientific stock
Published on 10/12/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- BofA raised its Thermo Fisher price target from USD 650.00 to USD 745.00 on October 9, 2026.
- Second-quarter revenue increased 10.00 percent to USD 11.99 billion, while adjusted earnings per share reached USD 6.03.
- Thermo Fisher stock was trading at EUR 588.30 at Lang & Schwarz on October 12, 2026, 0.39 percent above the Xetra close of EUR 586.00.
- The next dividend payment is scheduled for October 15, 2026, and third-quarter results are due October 21, 2026.
BofA raised its Thermo Fisher price target from USD 650.00 to USD 745.00 on October 9, 2026, while keeping a Buy rating, according to Markets Insider. Thermo Fisher Scientific stock was trading at EUR 588.30 at Lang & Schwarz on October 12, 2026 at 11:05 a.m. CEST, 0.39 percent above the Xetra close of EUR 586.00 on October 9, 2026.
Three dated signals shape the story
On July 23, 2026, Thermo Fisher reported second-quarter revenue of USD 11.99 billion, up 10.00 percent year over year, and adjusted earnings per share of USD 6.03, according to the company's earnings call transcript published by Yahoo Finance. On October 7, 2026, Barclays raised its target from USD 650.00 to USD 750.00 while maintaining an Overweight rating, as reported by Markets Insider. BofA's October 9 target move to USD 745.00 is the latest of the three signals.
What supports the higher target?
The second-quarter operating picture gives the analyst action a measurable foundation. Adjusted operating income increased 15.00 percent to USD 2.73 billion, and adjusted operating margin expanded by 90 basis points to 22.80 percent, according to Yahoo Finance. Management also raised fiscal 2026 adjusted earnings-per-share guidance to USD 24.93-25.33, a range representing 9.00-11.00 percent growth over fiscal 2025.
The counterweight is valuation. The latest market data show a USD 243.3 billion market capitalization and a USD 435.27 to USD 694.33 52-week range as of October 9, 2026. BofA's USD 745.00 target is USD 87.00 above the USD 658.02 primary-market price cited for October 9, 2026, but the target and the euro reference price use different currencies and are not combined.
Two dates now matter
Thermo Fisher's next dividend payment is scheduled for October 15, 2026, with a quarterly payout of USD 0.47 per share, according to MarketBeat. The company is scheduled to release third-quarter results on October 21, 2026, according to FinanzNachrichten.
Stock stays below its yearly high
Thermo Fisher's euro quote remains EUR 106.03 below the 52-week high equivalent shown in the same euro market context, while the current Lang & Schwarz price is 0.39 percent above the Xetra close of October 9, 2026. The combination of raised targets, higher guidance and an approaching results date leaves the next report as the clearest test of whether the growth rate can support the stock's elevated valuation.
The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 12, 2026, 11:05 a.m. CEST: EUR 588.30
- Change versus Xetra close: plus 0.39 percent
- Xetra close October 9, 2026: EUR 586.00
- Market capitalization: USD 243.3 billion as of October 9, 2026
- 52-week range: USD 435.27-694.33 as of October 9, 2026
- Sector / Industry: Healthcare / Medical Diagnostics and Research
- Index membership: S&P 500
Market context: Market report S&P 500.
